A new molecular imaging agent targeting glypican-3 (GPC3) has shown high sensitivity and specificity in detecting hepatocellular carcinoma (HCC), according...
PET imaging improves oligometastatic breast cancer detection over conventional imaging, according to a post-hoc analysis presented June 21 at the...
A new PET radiotracer rapidly detected and localized life-threatening mold-related invasive fungal infections, according to a presentation June 23 at...
NEW ORLEANS – A new radioligand therapy that targets two key cancer markers simultaneously has been shown to be safe...
NEW ORLEANS: In an interview at the Society of Nuclear Medicine and Molecular Imaging annual meeting, Phillip Kuo, MD, PhD,...
NEW ORLEANS – The combined use of two PET imaging agents provides a comprehensive imaging approach for managing patients with...
NEW ORLEANS – Retreating prostate cancer patients with lutetium-177 radioligand therapy after they have completed their initial course appears to...
NEW ORLEANS – Two newly developed PET imaging agents are effective for identifying a highly expressed receptor in neurological and...
NEW ORLEANS – Post-therapy SPECT/CT is invaluable for patients undergoing radiopharmaceutical therapy, according to a June 21 presentation Society of...
Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.